Geranylacetone

CAS No. 3796-70-1

Geranylacetone( —— )

Catalog No. M21257 CAS No. 3796-70-1

Geranylacetone has trypanostatic activity and could protect animals against the T. congolense-induced anaemia through the inhibition of sialidase and/or the protection of the parasite-induced hepatosplenomegaly.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Geranylacetone
  • Note
    Research use only, not for human use.
  • Brief Description
    Geranylacetone has trypanostatic activity and could protect animals against the T. congolense-induced anaemia through the inhibition of sialidase and/or the protection of the parasite-induced hepatosplenomegaly.
  • Description
    Geranylacetone has trypanostatic activity and could protect animals against the T. congolense-induced anaemia through the inhibition of sialidase and/or the protection of the parasite-induced hepatosplenomegaly.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3796-70-1
  • Formula Weight
    194.31
  • Molecular Formula
    C13H22O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(=O)CC\C=C(/C)CC\C=C(\C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Saad Bello Saad et al. Trypanostatic activity of geranylacetone: mitigation of Trypanosoma congolense-associated pathological pertubations and insight into the mechanism of anaemia amelioration using in vitro and in silico models.[J]. Experimental parasitology 2019.
molnova catalog
related products
  • GSK2256294A

    GSK2256294A is potent, selective inhibitor of recombinant human, rat and mouse sEH with IC50 of 27 pM, 61 pM and 189 pM, respectively.

  • MSC-4106

    MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .

  • Xipamide

    Xipamide is a sulfonamide-based diuretic with antihypertensive properties. Xipamide selectively inhibits anion exchanger.